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Previous studies and experiments on animals have shown that nonsteroidal anti-
inflammatory drugs (NSAIDs) could negatively influence bone healing. These results 
are applicable to humans. Therefore, many patients with fractures are recommended 
not to use these popular analgesics despite a lack of real evidence from randomized 
clinical trials indicating that these drugs are harmful to patients with fractures. 
 
This study, therefore, investigates the effect, if any, of ibuprofen on bone 
consolidation in the distal radius. The hypothesis is that brief treatment with ibuprofen 
does not hamper bone healing. The aim is also to compare the pain-relieving effect of 
ibuprofen to a placebo. The expectation is that this study might contribute to better 
pain management and rehabilitation, thereby making the entire course of treatment of 
Colles’ fractures more comfortable and safer for patients. 
METHODS 
The study was designed as a non-inferiority trial. A total of 191 patients (age 40 - 85 
years) with Colles’ fractures were included at Aalborg University Hospital. The 
patients were divided into two treatment divisions. The conservative division 
consisted of those patients with stable Colles’ fracture (Older classification, type 1 - 
2), treated with a plaster cast. The surgical division was scheduled for patients 
presenting with an unstable fracture (Older classification, type 3 - 4), treated with 
external fixation. 
Three groups of participants were randomly allocated in each division; the 7-days 
ibuprofen group was assigned to 600 mg x 3/day for 7 days, the 3-days ibuprofen 
group was assigned to 600 mg x 3/day for 3 days but then a placebo x 3/day for the 4 
days that followed, and the placebo group was given a placebo x 3/day for one week. 
Paracetamol was dosed to all patients, 1g x 4/day for seven days, and tramadol 50 mg 
on request. 
The primary outcome was radiological migration of bone fragments, variation in 
radius tilt, length, and inclination seen within the first 5 - 6 weeks (depending on 
conservative or surgical treatment) after injury. 
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The secondary outcomes were: 
The Disabilities of the Arm, Shoulder, and Hand (DASH) score;     
Range of motion (ROM) of the injured wrist (range of motion difference in the injured 
and contra-lateral wrist as a percentage); 
The percentage difference of bone mineral density (BMD) for the injured and non-
injured forearm; 
Changes in biochemical bone biomarkers (Serum CrossLaps and Osteocalcin) during 
the one-year follow-up;  
Histomorphometric estimations (the percentage of the volume and surface fractions 
in the callus biopsy) at six weeks after surgery;   
Patients’ pain experience during the first 14 days and the recorded consumption of the 
rescue medicine.   
The intention to treat method was chosen for these analyses. 
RESULTS 
The observed radiological migration between the groups in the conservative division 
revealed neither clinically important nor statistically significant differences (0.09  P 
 0.5), and the same in the surgical division (0.12  P  0.87).    
The DASH score (0.2 ≤ P ≤ 0.9) was not influenced by ibuprofen treatment; neither 
was the ROM (0.1 ≤ P ≤ 0.9). 
During the one-year follow-up, patients regained 87 - 95% of normal wrist movements 
amplitude. 
The injured radius, when compared to the non-injured contra-lateral bone, had a 3 - 
7% higher BMD. Findings were not influenced by ibuprofen therapy (0.69 ≤ P ≤ 0.72). 
Additionally, this study did not demonstrate any influence of the study drug on the 
concentration of CrossLaps (0.06 ≤ P ≤ 0.95) and Osteocalcin (0.15 ≤ P ≤ 0.99) during 




The differences between study groups in callus’ volume and surface estimations were 
not significant (0.38 ≤ P ≤ 0.99).  
Conservatively treated placebo group patients experienced more intense pain by 1.3 
VAS-point than the ibuprofen groups (P = 0.02) during the first three days. In the 
surgical division, the tramadol use during the perioperative period was of a lesser 
extent among the ibuprofen patients than the placebo group (P = 0.035), the level of 
the pain symptoms did not differ significantly (P = 0.4). 
The most frequent adverse events observed were gastrointestinal disorders along with 
finger dysesthesia. In the conservative division, we observed the highest adverse event 
percentage in the 3-days ibuprofen group compared with the placebo (56.6%, P = 
0.03). In the surgical division, the percentage was highest in the 7-days group versus 
placebo (55.1%, P = 0.043). 
CONCLUSIONS 
Compared to placebo, the introduction of ibuprofen in the acute phase was not inferior 
regarding to the radiological, functional, densitometrical, biochemical, and 
histomorphometric outcomes in both divisions and across all treatment groups. 
Ibuprofen treatment demonstrated better pain relief for conservatively treated patients 
and a tramadol-sparing effect for surgically treated patients. 
According to our study, ibuprofen may be prescribed as a bone-neutral analgesic in 













Det er en almindelig opfattelse at smertestillende gigtpræparater forsinker 
knogleheling. Den viden er imidlertid mest baseret på retrospektive studier, ikke 
kontrollerede studier eller dyreeksperimentelle undersøgelser, hvis resultater er gjort 
gældende for mennesker. Mange patienter med knoglebrud må derfor undvære den 
smertestillende effekt af ibuprofen, selv om der mangler randomiserede kontrollerede 
studier for, at denne behandling er skadelig for patienter.  
Formålet med dette studie var at undersøge, om ibuprofen påvirker knogleheling. 
Hypothesen var at kort behandlingskur med ibuprofen ikke vil have negative 
indflydelse på knogleheling. Formålet var også at sammenligne den smertestillende 
effekt af dette præparat med placebo. Forventningen var, at undersøgelsen kunne 
optimere smertebehandling, gøre genoptræningen samt hele behandlingsforløbet mere 
komfortabel og sikrere for patienter. 
METODER 
191 patienter med Colles’ fraktur (40 - 85 år) blev inkluderet på Aalborg 
Universitetshospital. De blev fordelt i to divisioner. Patienter med en stabil Colles’ 
fraktur (Older klassifikation, type 1 - 2) blev tildelt den konservative division og 
behandlet med en gipsskinne. Patienter med ustabil Colles’ fraktur (Older 
klassifikation type 3 - 4) blev tildelt kirurgisk division og behandlet med ekstern 
fiksation.  
Patienter i hver division blev randomiseret i 3 grupper: 7-dages ibuprofen gruppe 
tog ibuprofen 600 mg x 3 i 7 dage, 3-dages ibuprofen gruppe tog kun ibuprofen i 3 
dage og placebo i de resterende 4 dage, placebogruppe fik placebo i alle 7 dage. Alle 
patienter fik desuden paracetamol behandling 1000 mg tablet 4 gange dagligt i 1 uge 
og tablet tramadol 50 mg efter behov. 
Det primære effektmål var radiologisk fragmentmigration - ændringerne i radius 
hældning, længde og inklination observeret i løbet af 5 - 6 uger (afhængig af 
behandling – konservativ eller kirurgisk).              
De sekundære effektmål var: 
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Funktionelle resultater - DASH score og de procentvise forskelle i 
bevægelsesamplituden mellem det skadede og raske håndled; 
Den procentvise forskel mellem mineraltætheden i det skadede og uskadte spoleben; 
Ændringer i biokemiske knoglemarkører (Serum CrossLaps og Osteocalcin) i løbet af 
et års opfølgning; 
Histomorfometrisk undersøgelse af callus 6 uger efter operation (volumens og 
overfladens fraktioner);  
Patientens smerteoplevelse og forbrug af tramadol inden for 14 dage. Alle analyser 
blev udført i overensstemmelse med hensigten at behandle. 
RESULTATER 
Behandling med ibuprofen havde ingen statistisk signifikant indflydelse på 
knoglefragment-migration hverken i den konservative division (0.09  P  0.5), eller 
den kirurgiske division (0.12  P  0.87).      
Behandling med ibuprofen havde ingen påvirkning af DASH score (0.2  P  0.9) 
eller den senere håndledsbevægelse, (0.1 ≤ P ≤ 0.96). Alle patienter i alle 
behandlingsgrupper fulgte det samme forbedringsmønster af håndledsfunktionen og 
nærmede sig 87 - 95% af den normale håndledsbevægelighed ved 1 års kontrol.     
Det brækkede spoleben havde i gennemsnit 3 - 7% større knogle mineral tæthed i den 
ultra-distale region sammenlignet med det uskadede spoleben hos samme patient. Der 
var ingen forskel mellem behandlingsgrupperne, 0.69  P  0.72.                             
Der var ingen signifikant forskel i målingerne af Serum CrossLaps (0.06  P  0.95) 
og Osteocalcin (0.15  P  0.99) mellem behandlingsgrupper i begge divisioner.            
Der blev ikke observeret nogle signifikante forskelle af volumens og overfladens 
fraktioner mellem behandlingsgrupper i den kirurgiske division (0.38  P  0.99).   
I den konservativt behandlede division havde patienter i ibuprofen-grupperne 1.3 
VAS-punkt lavere smertescore i de første 3 dage, sammenlignet med placebogruppe, 
(P = 0.02). I den kirurgisk behandlede division havde ibuprofen ingen indflydelse på 
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patienternes smertescoring (P = 0.4). Men patienter, som fik ibuprofen, havde 
signifikant lavere forbrug af tramadol i de første 3 dage (P = 0.035). 
Mave-forstyrrelser og fingersnurren var de hyppigste bivirkninger. Der blev 
registreret flest bivirkninger i konservativt behandlede 3-dages ibuprofen gruppe 
(56.6%, P = 0.03 sammenlignet med placebo) og kirurgisk behandlede 7-dages 
ibuprofen gruppe (55.1%, P = 0.043 sammenlignet med placebo). 
KONKLUSION 
Behandling med ibuprofen i den akutte fase havde ingen indflydelse på de 
radiologiske, funktionelle, densitometriske, biokemiske og histomorfometriske 
effektmål, sammenlignet med placebo. Behandling med ibuprofen resulterede i lavere 
smertescore hos konservativt behandlede patienter og lavere tramadol-forbrug hos 
opererede patienter. 
Resultaterne af dette studie indikerer, at ibuprofen kan ordineres som knogle-neutral 
smertestillende medicin for Colles’ frakturpatienter. Man skal dog tage hensyn til 
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CHAPTER 1. PREFACE 
The current Ph.D. thesis was submitted as part of the requirement for attaining a Ph.D. 
degree at the Faculty of Medicine and The Doctoral School in Medicine, Biomedical 
Science, and Technology, University of Aalborg. 
The scientific work was conducted between 2010 and 2017 during the appointment as 
an orthopedic surgeon at Aalborg University Hospital, Department of Orthopedic 
Surgery. 
The following papers, which were based on data from the randomized controlled trial 
‘The influence of ibuprofen on healing of Colles’ fracture’, formed the basis for this 
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healing after Colles’ fracture – a randomized controlled clinical trial. Injury. 
2019:1-9. doi:10.1016/j.injury.2019.06.011 (1). 
 
II. Aliuskevicius M, Ostgaard SE, Hauge EM, Vestergaard P, Rasmussen S. 
Influence of Ibuprofen on Bone Healing After Colles’ Fracture: a randomized 
controlled clinical trial. J Orthop Res. October 2019. doi:10.1002/jor.24498 (2). 
 
III. Aliuskevicius M, Ostgaard SE, Vestergaard P, Rasmussen S. The influence of 
Ibuprofen on Healing of Nonsurgically Treated Colles’ Fractures. Healio 









CHAPTER 2. INTRODUCTION 
2.1. BACKGROUND 
Nonsteroidal anti-inflammatory drugs (NSAIDs) have been used in pain, fever, and 
inflammation treatment since the nineteenth century and are among the most 
commonly used analgesics (4). NSAIDs, and in particular ibuprofen, show treatment 
potential for acute fracture pain similar to morphine (5), and have an opioid-sparing 
effect (6–9).  
Severe acute pain is an indicator for prescribing opioids, and short-term treatment 
with opioids may lead to long-term use (8). Opioid consumption has increased by 
200% in the United States during the last 14 years and caused more than 33,000 deaths 
in 2015 (9). NSAIDs can be used as an additive therapy or even an alternative 
analgesic treatment. Following major surgery, NSAIDs can negate the need for 
opioids (10) and shorten the required hospital stay (11). Nonetheless, NSAIDs are 
likely to cause impaired fracture consolidation and are avoided after bone surgery, 
despite their benefits (12,13).  
The main reason for exercising caution in prescribing NSAIDs after bone surgery is 
their inflammation-inhibiting potential. Inflammation is a crucial process in the initial 
phase of fracture consolidation, as mechanical destruction of bone cell membranes 
leads to a release of arachidonic acid, later to be transformed into pain-mediating 
prostaglandins by cyclooxygenase-2 (COX-2) (Figure 2.1). Broken vessels 
immediately after injury give rise to fracture hematoma, resulting in hypoxia, low pH, 
migration of cytokines, and inflammation-mediating cells (Figure 2.2) (14). 
Cyclooxygenase-2 levels also increase, exhibiting pro-inflammatory activity and 
leading to angiogenesis and mesenchymal cells differentiating into osteoblasts (15). 
Numerous studies on animals have shown NSAIDs to have a potential delaying effect 
on bone healing (16), although this apparent healing delay requires that NSAIDs are 
used for more than just a short period (17). Impairing osteogenesis, NSAIDs might be 
helpful in preventing ectopic ossification after total hip arthroplasty if administered 
shortly after surgery (18). On the other hand, the loosening of prosthetic components 
mostly occurs in patients treated with NSAIDs for 7 - 14 days (18). Therefore, the 
influence of short NSAID therapy (3 - 7 days) on fracture consolidation is not yet 
sufficiently clarified (19,20).  
There is a discrepancy between animal studies, indicating the apparent negative effect 
of NSAIDs and clinical observations (21). This issue might be explained by different 
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fracture localization between animal models and clinical studies. Many animal models 
depict fracture healing in shafts, whereas humans suffer (in most cases) from 
metaphyseal fractures (21). The nature of the healing in these two localizations is 
different. Healing in metaphyses is initiated by local marrow cells. It is not as 
dependent on cell migration from the periosteum and surrounding tissue into the 
fracture via the bloodstream, as in the case in shaft fractures (22). 
From a methodological point of view, trying to understand the influence of NSAIDs 
on bone healing is challenging because of the numerous confounding factors (e.g., 
smoking, diabetes, obesity) that might affect bone healing (12). There is a clear need 
for prospective clinical studies in the future, designed with appropriate care (23,24). 
A fracture in the distal radius might be an object of such an investigation. The United 
States alone reported over 1.46 million new episodes in 1998. It is a common injury, 
making up for 1.5% of all emergency department admissions (25). There are 15,000 
new cases reported in Denmark every year (26). Many older patients experience 
secondary displacement of a bone fragment and may also suffer from a loss in wrist 
function after such fracture (27).  
Several groups of tools are available to assess the healing process in bone, such as 
imaging studies, clinical examination, serological markers (28), or histomorphometry 
(29). 
Fragment migration is a sign of higher instability of the Colles’ fracture (30,31). 
Severe comminute Colles’ fractures tend to experience secondary displacement 
during the first few weeks, with a volar tilt moving towards a dorsal tilt and a loss of 
radial inclination and length (30,31). Lack of radiological healing and secondary 
dislocation or migration of the fractured bone fragments during the 5/6-week follow-
up period are clinically important events (31). This pattern is not only characteristic 
of displaced Colles’ fractures treated with plaster casts (32); it may also appear after 
surgical fixation (33). The wrist joint may suffer a loss of reduction, negatively 
influencing its proper function in later life (34).  
The non-invasive method of choice used to determine the bone mineral density 
(BMD) is dual-energy X-ray absorptiometry (DXA scanning), widely used as a 
diagnostic tool for osteoporosis. Traditional radiographs can result in inter-physician 
variability of up to 20 - 25% (35) when used for evaluating healing fractures, whereas 
DXA scanning, focusing on the mineralization process in the maturing callus, allows 
a more quantified evaluation. Previous studies have reported a strong positive relation 
between BMD and mechanical rigidity of the new-formed bone (36), and despite not 
being the tool of choice in orthopedic surgery, DXA scanning is gaining popularity in 
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experimental studies. This method has been used in evaluating NSAID influence on 
osteoneogenesis in animals (37) and is a potent tool for better assessment of bone 
unification in clinical orthopedics (35). 
Another tool that can be used to detect physiological hindrance in fracture recovery is 
osseous biomarkers. The destruction of bony material precedes the creation of a new 
osteo-matrix (38). Type I collagen is synthesized primarily in bone and makes up over 
90% of the organic matrix (39). C-terminal telopeptide (CrossLaps) is released from 
the collagen (40) and minor peptide particles appear in the blood circulation after the 
damage and destruction of bony material. Immunoassays can measure the 
concentration of circulating telopeptide until it is eliminated by renal excretion. 
Furthermore, the increased activity of osteoblasts during the subsequent fracture 
healing process can be assessed by evaluating serum osteocalcin concentration, the 
product of osteoblasts (41), thereby monitoring the bone remodeling process (42). 
Bone markers are useful as a non-invasive, dynamic method of investigation of 
healing callus (43). These serum levels present wide-ranging variation in individuals 
depending on the severity of the injury, the surgery performed (44), and circadian 
instability (40). 
Histomorphometry, or "bone callus counting", is another method with the potential 
for investigating bone repair (29). Qualitatively assessed bone structures can be 
counted and quantified in terms of bone (lamellar and woven), fibrous tissue, osteoid 
volume fractions, and expressed as the percentage of the total tissue volume. The bony 
healing process and its resorption and regeneration phases can also be evaluated by 
estimating bone surface fractions (45). Regeneration of bone is represented by a bone 
surface covered with osteoid and/or osteoblasts, whereas surfaces covered by 
osteoclasts indicate bone destruction/resorption during fracture healing (46). 
Colles’ fractures cause pain in the early acute phase and thus raise the indication for 
the use of analgesics (47,48). Therefore, the research question arises if a brief 
treatment with ibuprofen is beneficial for patients with Colles’ fractures, and whether 
this can decrease the demand for morphine medications. The question is even more 
pertinent if the fracture is displaced, as the treatment in these cases relies on surgery, 
and the patients will likely experience even more pain during the first days after injury 
(49). 
Treatment with NSAIDs may, theoretically, be beneficial for fracture patients. By 
suppressing inflammation, NSAIDs decrease edema and pain, which are the 
dominating symptoms in the early phase of fracture healing (47), thereby making 
rehabilitation more comfortable and efficient. The investigation object might be 
ibuprofen, the most commonly sold NSAID in Nordic countries (50).  




























Converted  by COX - II Inhibited by NSAID 
Mechanical damage 
The research questions are: 
1. Is ibuprofen harmful to patients with Colles’ fractures due to delayed osteogenesis 
in terms of higher fragment migration, impaired wrist function, lower bone 
mineralization, affected dynamics in bone biomarkers, and delayed histologic callus 
maturation? 

















                                                                                                                                         
Figure 2.1. Pathophysiological mechanisms of inflammation after bone damage. 
























Figure 2.2. Inflammatory mechanisms in the fracture hematoma (reproduced from 
reference No. 14). 




1. H0: Treatment with ibuprofen causes inferior results in radiological, 
functional, DXA, biochemical, and histomorphometric outcomes (non-
inferiority design). 
HA: There is no difference in radiological, functional, DXA, biochemical, and 
histomorphometric outcomes (non-inferiority design). 
2. H0: There is no difference in patients’ pain experience and tramadol 
consumption between ibuprofen and placebo treatment groups (superiority 
design). 
HA: Treatment with ibuprofen provides different analgesic and tramadol 
consumption outcomes (superiority design). 
 
2.3. AIM 
This work primarily aimed to test the above-mentioned hypotheses by conducting a 
non-inferiority randomized placebo-controlled triple-blind clinical trial entitled 
“Ibuprofen’s influence on the healing of Colles’ fracture” and to assess 
radiological bone fragment migration.  
The second aim was to evaluate wrist function, bone mineral density, changes in 
biochemical bone markers, histological parameters of healing bones, patients’ pain 
experience during the first 14 days, and tramadol consumption as a rescue medicine. 
The third aim was also to determine the level of reliability and bias in evaluating of 
X-ray pictures and bone tissue. To check the intra-observer repeatability, a calculation 
of the difference between two radiological assessments was performed. For estimation 
of histomorphometric parameters, a coefficient of variation (CV%) between two 








Tp 1: dorsal angulation ≤ 5 degrees, 
length of radial styloid ≥ 7mm;                                                                                                     
Tp 2: dorsal angulation > 5 degrees, 
length of radial styloid  < 7 and ≥ 
1mm;                                                                  
Tp 3: dorsal angulation > 5 degrees, 
length of radial styloid  ≤ 4mm slight 
dorsal comminution;                                          
Tp 4: dorsal angulation > 5 degrees, 
length of radial styloid usually 
negative, comminution, often intra-
articular involvement. 
 
CHAPTER 3. METHODOLOGICAL 
CONSIDERATIONS 
3.1. STUDY DESIGN 
The study was conducted as a prospective, randomized, triple-blind placebo-
controlled non-inferiority trial. Patients were included in the study if they were aged 40 - 
85 years old, gave written informed consent, and had a Colles’ fracture. 
The patients meeting the inclusion criteria were allocated to one of two treatment 
divisions after written consent. The conservative division consisted of those patients 
with stable Colles’ fracture, Older classification, type 1 - 2 (27), treated conservatively 
with a plaster cast. The surgical division was scheduled for patients with unstable 









Figure 3.1.  Older classification of Colles’ fractures (reproduced from reference No. 
27).  
Patients were excluded from the study if they were younger than 40 or older than 85 
years of age, were systematically treated with NSAIDs, had a previous fracture of the 
wrist in question, or were unable to follow the relevant instructions due to poor mental 
and/or physical condition, had medical contraindications to the use of NSAID’s, or 
were pregnant. Patients with secondary fracture-displacement with a need for re-
/operation (displacement back to type 2 - 3 despite initial conservative treatment or 
type 3 - 4 despite initial surgery) were excluded from the study. 
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Patients in each division were randomly assigned to receive the appropriate 
intervention analgesic. 
All patients were treated at the Department of Emergency Medicine and the 
Department of Orthopedic Surgery, Aalborg University Hospital. All study 
participants were included within three days of the injury occurring. Patients began to 
register their pain in a pain diary from the moment of inclusion in the study and 
continued for 14 days. 
The following evaluations were made during the follow-up period: 
• At the Emergency Department: X-ray and pain evaluation before and after 
fracture reduction or cast immobilization only (if the fracture did not need 
reduction). 
• Preoperatively (surgical division): X-ray evaluation, bone biomarkers. 
• 1-week follow-up: X-ray evaluation and measurement of the range of motion 
in the uninjured wrist, bone biomarkers. 
• 2-week follow-up: X-ray evaluation, collection of the pain diary, bone 
biomarkers. 
• 5-week follow-up (conservative division): X-ray evaluation, removal of the 
plaster cast, bone biomarkers, measurement of the range of motion of the 
injured wrist, and training instructions. 
• 6-week follow-up (surgical division): X-ray evaluation, removal of the 
external fixator, bone biomarkers, callus biopsy, measurement of the range 
of motion of the injured wrist, and training instructions. 
• 3-months follow-up by the occupational therapist: completing the DASH 
questionnaire and measurement of the range of motion of the injured wrist, 
DXA-scanning, bone biomarkers. 
• 1-year follow-up by the occupational therapist: completing the DASH 
questionnaire and measuring the range of motion of the injured wrist, bone 
biomarkers.   
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3.2. RANDOMIZATION AND BLINDING 
The department allocated pharmacy unit was responsible for dispensing and 
conducted the block randomization (5×9 + 8×6 + 1×3). The medicine was supplied to 
the patients in packets according to the randomization process. The patient, surgeon, 
investigator, and statistician had no information regarding allocated therapy. Only the 
project-related dispenser knew the medicine bag’s exact contents. Unblinding was 
performed in two steps: 
Step 1. Partial unblinding was performed for the data analysis. Patients allocation to 
one of the three treatment groups (group one, group two, and group three) was 
disclosed. No information regarding the ibuprofen treatment was revealed at this 
point.  
Step 2. After completing the statistical analysis, total unblinding was performed with 
detailed information regarding treatment with ibuprofen or placebo. 
 
3.3. INTERVENTION 
Ibuprofen (ATC-code: M01AE01) was chosen as the NSAID medication for acute 
pain treatment. Ibuprofen’s absorption from the digestive channel and subsequent 
analgesic effect is fast; the maximal plasma concentration is achieved within 1 - 2 
hours after oral intake; nonetheless, the effect is brief, and the plasma half-life is 1.5 
- 2 hours. 
The recommended daily dose of ibuprofen is 1.2 - 1.8 g divided over three 
administrations; therefore, 600 mg tablets of ibuprofen were administered 1x3 daily 
to ensure sufficient doses for acute pain treatment. 
Participants were randomly assigned in a 1:1:1 ratio to receive either 600 mg of 
ibuprofen 1x3 per day for one week (7-days group), or 1 x 3 per day for the first three 
days, followed by the placebo 1x3 daily for the next four days (3-days group), or 
placebo-only 1x3 per day for the entire 7-days course (placebo group) (1–3). 
Participants who signed the participation agreement form received a 7-days package 
of dosed analgesics and a diary to register their pain for 14 days. Each bag was 
individually numbered and contained paracetamol for 1 g taken 1 x 4/day for seven 
days, six 50 mg tramadol rescue-tablets, and the predefined amount of either 
ibuprofen or placebo (or both) for seven days. The study participants received no acid-
neutralizing agents in order to avoid unnecessary treatment for placebo groups. 
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3.4. COLLES’ FRACTURE AND TREATMENT 
A Colles’ fracture is a fracture of the distal radius with both a dorsal and radial 
displacement of the wrist and hand. The fracture is commonly caused by falling onto 
a hard surface with outstretched arms. The typical picture of a displaced fracture is 







Figure 3.41. Displaced Colles’ fracture. 
In this study, displaced Colles’ fractures are characterized by a fracture in the 
metaphysis of the distal radius, the distal fragment tending to tilt dorsally and radially, 








Figure 3.42. X-ray picture of a displaced Colles’ fracture. 
Older type 1 Colles’ fracture was immobilized in the dorsal forearm plaster cast 
without reposition (Figure 3.43). 









Figure 3.43. Dorsal forearm plaster cast. 
Older type 2 - 4 fractures were treated with local hematoma anesthesia injecting 10 
milliliters of 0.5 percent of lidocaine. The closed reduction was subsequently 
performed by traction in the line of the forearm and firm pressure on the distal 











Figure 3.44. Hematoma anesthesia. Technics of closed reduction of Colles’ fracture.  
The unstable Colles’ fractures of Older type 3 - 4 were treated surgically afterwards. 
We selected an external fixation-type bridging with a Hoffmann II external fixator 
(Sryker®, MI, USA), and additional 1.4 mm K-wires as the standard surgical method 
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(1,2). The intervention is recognized both in Denmark (51) and worldwide (52) and is 
used to treat unstable fractures (33). Furthermore, this technique allows a bone biopsy 
to be performed six weeks later while removing the external fixator and K-wires and 
assessing of BMD in recovering distal radius.                                         
The maximum possible standardization of the treatment was obtained by ensuring the 
same surgeon performed all interventions for the enrolled participants. All operations 
were performed in the same way, using the following three steps: 
1. Closed reduction using finger distraction devices with 2.5 - 3 kg weights. 
2. Fixing the fragments in the proper position using 1.4 mm K-wires (Figure 
3.45) placed dorsally into the fracture (to ensure the proper tilt of the distal 
fragment) and radially through both main fragments of the fracture (to ensure 
the proper length and inclination of the distal radius) using a modified 
Kapandji technique (53). 
3. Locking the wrist joint in a neutral position using Hoffmann II external 
fixator (Sryker®, MI, USA) type bridging to minimize the risk of secondary 
dislocation. The proximal fixator pins are placed 7 cm proximally to the 
fracture; the distal pins are placed in the proximal/middle third of the second 
metacarpal (Figure 3.46).  
An infra-clavicular regional nerve block was applied to all patients, either with or 








Figure 3.45.  Perioperative X-ray pictures. 












Figure 3.46. Bridging external fixation. 
 
3.5. RADIOLOGICAL EVALUATION 
Three radiological outcomes (Figure 3.5) were predefined (1,3):  
1. The inclination in the antero-posterior view is defined as the angle between 
the ulnar corner of the radius in the wrist joint and the radial styloid’s tip. 
2. The length in the antero-posterior view is defined as the interval from the 
radial styloid’s tip to the horizontal (lowest) joint surface of the distal radius. 
3. The tilt in the lateral view is defined as the angle between the distal radius 













Figure 3.5. Measurement of radiological outcomes. 
The same individual performed all the measurements. X-ray pictures were evaluated 
before the reposition, after the reposition, perioperatively, and at 1, 2, and 6 weeks 
after the surgery (5 weeks in the case of conservative treatment). All assessments were 
performed using the EazyViz software package (     0413, Karos Health Incorporated, 
Copenhagen, Denmark), a digital system for primary diagnosis and clinical evaluation 
of radiographs, which allows determining the angle and distance between points of 
interest.  
The assumption was that fracture fragments would move, thus changing the intra-
operative achievements to a less desirable result (32,34,54). The severity of 
dislocation regarding radius tilt, length, and inclination, was evaluated by calculating 
the difference between the fragments' position directly after treatment and 5/6-weeks 
later. 
To check the observer’s repeatability, the original X-ray pictures were reevaluated 
after three months by the same observer. The mean difference between the two 
observations, with a 95% confidence interval, was determined. 
 
3.6. EVALUATION OF THE WRIST JOINT FUNCTION 
One of the functional outcomes was the range of motion (ROM) in the injured wrist 
joint compared to a healthy one. Wrist range of movement was measured in the 
following directions, resulting in three outcome values: flexion/extension range, 
pronation/supination range, and radial/ulnar deviation range (1,3). As the physiologic 
range of movement differs between individuals (55), the healthy wrist movement was 
assessed as the baseline. The injured wrist's ROM was assessed during five/six weeks, 
three months, and one-year follow-up sessions. The outcome was calculated as a 
percentage of the healthy wrist's ROM.  
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Two occupational therapists performed all the measurements for this part of the study. 
Wrist joint motion was measured according to the Danish National Standard 
guidelines (56). Descriptions and pictures are enclosed with the permission of the 
author, Helle Puggård Hansen (Figures 3.6 - 3.9). 
The second functional endpoint was the assessment of the daily Disabilities of the 
Arm, Shoulder, and Hand (DASH) score. The DASH test is considered a prompt and 
trustworthy evaluation tool for the patient’s everyday function (57,58). Participants 
filled in the DASH survey form with an occupational therapist’s assistance three 
months after the injury (6 - 7 weeks after the beginning of wrist rehabilitation) and at 
the final one-year control. 
The DASH questionnaire used was a Danish translation of the daily activities module 
and contained 30 questions regarding everyday situations in daily life. Each question 
regarding how difficult it was to perform a specified function in daily life was 
answered using a scale consisting of five points where the answer ‘without 
difficulties’ equaled one point, and the answer ‘unable’ equaled five points. DASH 
questionnaires containing more than three unanswered questions were removed from 
the analysis. 
The value of the DASH measurement was calculated using the formula: [((sum of n 
responses)/n) - 1] * 25, n being the number of answered questions (1).  
 
 
MEASUREMENT OF THE WRIST MOTION 
Measurement of supination (Figure 3.61)                                                                     
Starting position: elbow held against the body and flexed 90°.  
Goniometers focal point: laterally for caput ulnae. 
Stable axis: corresponding to the center line of the humerus. 


















                                                                                                                                            
Figure 3.61. Measurement of supination. 
Measurement of pronation (Figure 3.62)                                                                                            
Starting position: elbow held onto the body and flexed 90°. 
Goniometers focal point: laterally for caput ulnae. 
Stable axis: corresponding to the center line of the humerus. 










Figure 3.62. Measurement of pronation. 
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Measurement of the dorsal - volar flexion (Figure 3.63)                                                                  
Starting position: forearm held in a neutral position. 
Goniometers focal point: radially distally to the radial styloid. 
Stable axis: along the radius. 








Figure 3.63. Measurement of the dorsal - volar flexion. 
Measurement of the radial - ulnar deviation (Figure 3.64)                                                               
Starting position: forearm in pronation with the volar side facing down.                                     
Goniometers focal point: dorsally, centrally over the carpus. 
Stable axis: dorsally on the forearm in a midline between the radius and the ulna. 








Figure 3.64. Measurement of the radial - ulnar deviation. 
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3.7. EVALUATION OF DENSITOMETRICAL OUTCOME 
A BMD outcome, the difference of mineral density in the fractured distal forearm 
compared with the contra-lateral healthy area, was measured with a Discovery A 
DXA-scanner (Hologic Inc., MA, USA). For lumbosacral BMD, the in-vivo accuracy 
was 0.90%, total hip 1.00%, and the femoral neck, 1.79% (2).  
We defined the ultra-distal zone (UD) as the region of interest, the area covering 30 
mm proximally from the distal radio-ulnar joint (Figure 3.7). According to the 
reference UD-BMD of the contra-lateral forearm, we registered the percentage of the 










Figure 3.7. DXA scanning, regions of interest of distal forearm. 
 
3.8. EVALUATION OF BIOCHEMICAL OUTCOMES 
A biochemical outcome - serum CrossLaps and Osteocalcin levels were determined 
by the Cobas e 411 ECLIA immunoassay analyzer (Roche Diagnostics®, Basel, 
Switzerland) (2,3). A medical laboratory technician collected the blood at 9.00 a.m. 
from fasting patients to prevent the varying circadian concentrations of biomarkers. 
The samples were taken for each patient before surgery and at one-week, two-weeks, 
three-months, and one-year controls. K3-EDTA, along with Li-heparin plasma, was 
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supplied in the tubes, which, after taking the sample, were stored at a temperature of 
5ºC. Bone biomarkers were then analyzed at the end of follow-up. The immunoassay 
was conducted after two-point calibration and creation of the master-curve of 
monoclonal anti-ß-CrossLaps and anti-N-MID Osteocalcin antibodies (mouse-
derived) (2,3).  
 
3.9. EVALUATION OF HISTOMORPHOMETRIC OUTCOMES 
A biopsy was taken from the callus at 6-weeks post-surgery, at the point when the 
Hoffmann II fixator and K-wires were removed. The spot of incision, mid-dorsal over 
the distal radius, was marked on the skin after being determined using an image 
intensifier. 5 ml of 0.55 Lidocaine was injected for local anesthesia, and a T-Lok™ 
Bone Marrow Biopsy Needle of 13 G (Product No. DBMNJ1304, ARGON® Medical 
devices, TX, USA) was used to retract a 5 - 7 mm extended callus tissue biopsy (2) 








Figure 3.91. Bone biopsy procedure. 
After placing in a plastic tube-container with 70% ethanol solution, the biopsy 
material was stored at 8ºC. Methylmethacrylate was used for embedding the biopsies 
after decalcifying. Sections of seven-micrometer thickness were performed using a 
Jung microtome K (R. Jung GmbH, Heidelberg, Germany) with a tungsten knife 
provided (2). To cover the largest possible area, a middle cut in the biopsies was 
performed in four levels with three sections per level with a distance of 175 µm 
between them. The staining was made with Goldner Trichrome (Figure 3.92). 












Figure 3.92. Stained section of biopsy material. 
In study groups, the following callus histomorphometric volume and surface estimates 
were compared: bone volume/tissue volume (BV/TV%), lamellar bone volume/tissue 
volume (LBW/TV%), woven bone volume/tissue volume (WBV/TV%), osteoid 
volume/tissue volume (OV/TV%), fibrous tissue volume/tissue volume (FV/TV%), 
and osteoid surface/bone surface (OS/BS%), osteoblast surface/bone surface (ObS/BS 
%), osteoclast surface/bone surface (OcS/BS%) (2,45).   
All analyses were performed by the same individual using an Olympus BH 
microscope with 200-times magnification and polarized lights facility (used to 
distinguish lamellar from woven bone) (2). All biopsies sections were assessed in five 
sight-fields per section using a 10×10 point ocular-grid for volume estimations 
(counting the number of times the point hit the tissue fraction of interest and dividing 
the number by the number of reference points hitting all the tissue in the sight field) 
(2). For surface estimations, ten-line-grids were used (counting how many times the 
lines intersect the bone surface fraction of interest and then dividing by the total 
number of bone surface intersections in the sight field). Random rotation of the line-
grid was performed before analyzing every new sight-field. Biopsies were randomly 
selected (10% of all samples) for evaluation three months later to depict the variation 
coefficient (CV) as an estimate of observer repeatability in this part of the study. The 
formula: CV = 100 ∗ √
∑(d m⁄ )2
2n
, where d - the difference between two observations, 
m - the mean of two observations, and n - the number of observations (2).  
























Figure 3.93. Histomorphometric assessment of bone tissue in normal and polarized 
light (reproduced from reference No. 2). 
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3.10. EVALUATION OF PAIN 
Patients registered their pain using a Likert 10-point assessment scale (59,60). Pain 
experience was recorded for 14 days from enrollment, three times daily in the 
morning, midday, and evening when the subject took the study medication. One point 
indicated 'no pain,' and 'unbearable pain' scored 10 points. Participants were also 
obliged to record their consumption of tramadol as a rescue-analgesic.  
The average daily pain was calculated for each patient in each treatment group. Three 
periods, at days 1 - 3, 4 - 7, and 8 - 14, were selected as pain outcomes. These periods 
corresponded to the treatment duration with ibuprofen 600 mg; two groups (the 3-
days and 7-days groups) received ibuprofen during the first period. Only one group 
(7-days group) received ibuprofen during the second period; no group was treated 
with ibuprofen during the third period. The escape medicine tramadol taken during 
these periods was also recorded for each day of analgesic follow-up. 
 
3.11. CONSENT 
We followed The CONSORT 2010 guidelines in this study (61). Written and signed 
informed consent was collected from all participants before they were included in the 
study. 
The project was conducted following the Good Clinical Practice guidelines (62) and 
following the conditions and allowance of the Danish Data Protection Agency, the 
Danish Regional Ethics Committee (registration number N-20100015), and the 
Danish National Medicine Agency (registration number 1253599). The study was also 
registered in the clinicaltrials.gov database (registration number NCT01567072) and 
the European Medicines Agency (EudraCT number 2010-018543-34). 
No financial sponsors of this randomized controlled trial contributed to designing or 
conducting the study, analyzing the data, or preparing the manuscripts. The primary 





CHAPTER 4. STATISTICAL METHODS 
4.1. SAMPLE SIZE 
Before completing the follow-up or performing any analyses, a detailed statistical 
analysis was published on the Aalborg University's web page (63). We determined the 
sample size with reference to this study's primary outcome; dorsal angulation of the 
distal radius fragment. 
Sample size estimation was performed to ensure the proper power for testing the null-
hypothesis of ibuprofen treatment being inferior to paracetamol-only therapy, 
resulting in more remarkable radiological fragment migration. Non-inferiority design 
and radiological fragment migration were chosen for the power and sample size 
calculation.  
A literature-based non-inferiority margin of one SD (64), equal to 9.4 (65), and an 8o 
reliable measurement limit (66) was set for this study, with the power defined at 90%. 
Thus to reject H0 when HA is true at a 0.05 level of significance, 132 respondents were 
required (i.e., 22 patients in every treatment group in both divisions). On the other 
hand, a total of 192 respondents (i.e., 32 patients in every treatment group in both 
divisions) were needed to estimate the normal distribution and allow a dropout rate of 
at least 20% (1,3).  
A posthoc sample size and power calculation for other outcomes were made, 
according to the standard deviation as a non-inferiority margin (64) in our study 
population and an overview of the literature. 
A one SD = 14.5% non-inferiority margin for the difference in the range of wrist 
extension/flexion, as the main important movement component (67), was used for the 
sample size calculation. It was estimated that 22 patients in each treatment group 
would yield a power of 0.90 with a significance level of 0.05, commonly used in non-
inferiority trials (68). 
According to the BMD difference between the injured and healthy UD zone of the 
distal forearm, posthoc sample size and power calculation were taken for 
densitometrical outcomes. We used a value of the standard deviation of the difference 
between the healthy-side BMD and post-fracture BMD for the calculation. In the 
literature, the standard deviation was reported to be 4.35% (69). Then, we subtracted 
1% error of precision (70) and determined a value of 3.35% as the non-inferiority 
margin in the sample size calculation. Therefore, to attain a power of 90% with a one-
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sided 0.05 level test, it was necessary to recruit 186 participants (three 31-patient 
groups in each of two divisions) (2).  
For the pain score, the sample size was calculated to test the null hypothesis 
(according to the superiority design) that there is no difference in patients’ pain 
experience between ibuprofen and placebo treatment groups. A minimal clinical pain 
score difference of 1.5 VAS-points was chosen (71). With a significance level of 0.05, 
a power of 90%, and an SD of 1.41 (71), a total of 23 patients were needed in each 
group. 
 
4.2. STATISTICAL METHODS OF THE OUTCOME ANALYZES 
Frequency histograms, boxplots, and Q - Q plots were employed to check each 
sample's distribution pattern (1,2). If there were homoscedasticity and normal 
distribution of the sample data, the ANOVA test was applied with a posthoc Tukey 
test if necessary.  
According to the initial statistical analysis plan (63), Student’s t-tests with a Dunn - 
Šidák correction were foreseen. In cases where a comparison had to be made between 
three groups, the α significance level with a Dunn - Šidák correction was α = 1 – (1 – 
0.05)1/3 = 0.017.  
Subsequently, the experience was that the ANOVA test was more applicable as it 
handles more than two samples and compares the variation within treatment groups 
to variation between treatment groups. Therefore, this test was applied in two of our 
publications; “Influence of ibuprofen on bone healing after Colles’ fracture - a 
randomized controlled clinical trial” (2) and “The Influence of Ibuprofen on the 
Healing of Nonsurgically treated Colles’ Fractures” (3). 
In this thesis, the ANOVA test is used to compare the outcomes between three 
treatment groups across the entire study. The change from t-test with Dunn - Šidák 
correction to ANOVA test did not influence the significance of our study results and 
conclusions. 
In case of a not normal distribution, we applied a Kruskal - Wallis nonparametric 
significance test. 
Additionally, to compare the severity of complications and adverse events between 
treatment groups, a Z-test was chosen.  
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The power was set to 90% for all tests. 
  
4.3. MANAGEMENT OF MISSING DATA 
The endpoint assessment suffered from some missing data due to improper quality 
of radiographs or biopsy, DXA scanning, blood analyses not being performed, or 
forgotten records in the patient’s pain diary, not answered questions of DASH 
survey. The missing values were multiply imputed in the database to avoid potential 
bias and increase the outcome's reliability. All imputations were reviewed to warrant 
the sane values being developed, and multiple imputations were applied on both 
baseline and outcome variables (63). 
 
4.4. STATISTICAL ANALYSIS PROCEDURE 
The statistical analysis plan published on the Aalborg University website was used to 
instruct the statistician performing the analyses. The same statistician performed all 
analyses using the statistical program package R. 
The statistical analysis procedure consisted of the following five steps:  
1. A “data collection form” was drafted as a teamwork platform between the study’s 
data manager (sponsor/investigator) and the statistician. 
2. The study pharmacist coded each therapy arm in both divisions as “group one,” 
“group two,” and “group three,” hence, blinded analysis of the data was ensured. 
3. The collection form containing blinded, raw data was transferred to the statistician. 
4. Primary and secondary outcome analyses were blinded regarding the therapy.  
5. Results were submitted to the trial investigator, after which any uncertainties were 








  placebo group 3-days ibuprofen group 7-days ibuprofen group 
Female\Male 22\8 17\7 17\9 
Mean age (years ± 1SD) 61.3 ± 8.3 63 ± 11.2 62 ± 9.9 
Smokers\Non-smokers 6\24 4\20 4\22 
Osteoporosis treatment +\- 1\29 0\24 0\26 
Dominating\Not 13\17 10\14 16\10 
Displaced/non-displaced 14/16 12/12 19/7 
Pre-treatment pain score 6.4 ± 2.6 6.2 ± 2.6 6.9 ± 2.5 
BMI 26.6 ± 3.2 26.5 ± 4.7 26.4 ± 4.3 
Total analyzed 30 24 26 
CHAPTER 5. SUMMARY OF RESULTS 
5.1. SCREENING, INCLUSION, AND FOLLOW-UP 
Between 1. June 2012 and 20. June 2015, a total of 564 patients were screened. 284 
of these patients had the Older type 1 - 2 Colles’ fracture, and 280 suffered from the 
Older type 3 - 4 fracture. 191 patients were enrolled in the study, an enrollment 
percentage of 33.8. There was a significant 2.5 ± 0.99 years difference between 
enrolled (mean age 63.7 years) and non-enrolled (mean age 66.2 years) patients, P = 
0.01. The proportion of males was 22% among enrolled individuals and 15% among 
non-enrolled individuals, P = 0.03.   
96 of the total of 284 patients with Colles’ fractures considered stable were recruited 
to the conservative division, an enrollment percentage of 33.8 (Table 5.11). 122 
patients were not informed about the study. 47 patients were not interested, and 19 
patients fulfilled the criteria for exclusion. 69 patients were women, the mean age 
being 62.1 ± 9.8 years. 91 of the enrolled participants received the study 
pharmaceuticals, five patients did not (met exclusion criteria, non-compliance). 19 
patients withdrew from participating while one patient lost his pain records. Three 
patients experienced nausea after treatment and quit the study. Seven patients were 
excluded because of secondary dislocations. Two patients did not undergo DXA 
scanning because of logistical reasons. The conservative division analysis was 
















Table 5.11. Baseline characteristics of the patients in the conservative division. 
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CONSORT FLOW DIAGRAM  
 
Assessed for eligibility from June 01, 2012 
until June 20, 2015 (N=284) 
Randomized (N=96) 
Not included (N=188) 
♦   Not asked (N=122) 
♦   Declined to participate (N=47) 
♦   Did not meet inclusion criteria 
(N=19) 
Allocated to intervention 
placebo group (N=32) 
♦ Received allocated 
intervention (N=31) 




Allocated to intervention 3-days 
ibuprofen group (N=32) 
♦ Received allocated intervention 
(N=30) 
♦ Did not receive allocated 
intervention (1-met exclusions 
criteria, 1–non-compliance (N=2) 
Allocated to intervention 7-days 
ibuprofen group (N=32) 
♦ Received allocated intervention 
(N=30) 
♦ Did not receive allocated 
intervention (1–mistaken 
inclusion of patient with 




1 lost at 1-2 weeks follow-up 
(secondary dislocation)                       
1 lost at 5 weeks follow-up (regret)                                                 
1 lost at 3 months follow-up (new 
fracture)                                              
2 lost at 1 years follow-up (regret)                         
5 lost at 1-2 weeks follow-up (1-side 
effects, 4- dislocation)                                     
1 lost at 3 months follow-up 
(secondary dislocation)                       
1 lost at 1 years follow-up due to lung 
cancer            
 
4 lost at 1-2 weeks follow-up 
(2 side effects, 2 secondary 
dislocation)                               
1 lost at 3 months follow-up 
(regret)                                     
2 lost at 1 years control (regret)                  
       
Follow-Up 
Analyzed:   
♦Pain in 14 days (N=30), 
♦Radiological migration (N=29)     
♦Functional outcomes  (N=25)       
♦DXA scanning (N=26)               
Not performed (N=1)             
♦Bone biomarkers (N=30)   
                             
Analyzed: 
♦Pain in 14 days (N=24), 1 lost pain 
diary                               
♦Radiological migration (N=24)                                     
♦Functional outcomes (N=23)       
♦DXA scanning (N=23)                
Not performed (N=1)                        
♦Bone biomarkers (N=24) 
 
Analyzed: 
♦Pain in 14 days (N=26)                   
♦Radiological migration (N=26)     
♦Functional outcomes (N=25)      
♦DXA scanning (N=26)               













































Figure 5.12. Conservative division - consort flow diagram (reproduced from 
reference No. 3). 




In the surgical division, 95 participants out of 280 screened with Older type 3 - 4 
Colles' fracture were recruited, an enrolment percentage of 33.9%. Of the initial 280, 
121 patients were not included due to time limitations at the hospital, 45 declared no 
interest in taking part, and 19 exhibited the exclusion criteria. One patient with a 
different fracture type than described in the protocol received a pack containing study 
medication. 
95 patients were included (Table 5.13). The largest proportion (N = 80) of participants 
were female, with a mean age of 64.7 ± 9.2 years. 89 out of the 95 recruited 
participants received the study medicine. The other six participants did not, either due 
to changing their mind or their noncompliance. Four patients subsequently withdrew 
their willingness to be a part of the study; three patients mislaid their pain-experience 
recordings; one participant experienced therapy-related side-effect (nausea) and 
cancelled further study treatment. One participant suffered unexpected death (by 
drowning accident) before the last follow-up visit. One participant, who received a 
different operation than described in the protocol, was excluded due to secondary 
displacement. As a result of poor-quality, one participant’s X-ray pictures were also 
excluded from the evaluation. For logistical reasons, it was not possible to perform 
DXA scanning on one patient. Finally, due to tissue material being of improper 
quality, four further patients were excluded from the histomorphometric evaluation. 
An intention to treat analysis was applied for 89 participants, allocated to three 
different treatment groups. (Figure 5.14). 
Table 5.13. Baseline characteristics of the study patients in the surgical division. 




Female\Male 25\5 25\5 24\5 
Mean age (years ± 1SD) 64.3 ± 4.4 67.8 ± 10 65.4 ± 7.9 
Smokers\Non-smokers 3\27 1\29 3\26 
Osteoporosis treatment +\- 6\24 5\25 7\22 
Dominating\Not 15\15 13\17 14\15 
Pre-treatment pain score 6.5 ± 2.7 6.8 ± 2.5 6.7 ± 2.3 
BMI 26.7 ± 4.6 24.9 ± 3.9  23.7 ± 3.5 
Total analyzed 30 30 29 




Assessed for eligibility from June 01, 2012 
until June 20, 2015 (N=280) 
Randomized (N=95) 
Not included (N=185) 
♦   Not asked (N=121) 
♦   Declined to participate (N=45) 
♦   Did not meet inclusion criteria (N=19) 
Allocated to intervention 
placebo group (N=32) 
♦ Received allocated 
intervention (N=30) 
♦ Did not receive allocated 
intervention (regret) (N=2) 
Allocated to intervention 3-day 
ibuprofen group (N=32) 
♦ Received allocated intervention 
(N=30) 
♦ Did not receive allocated intervention 
(non-compliance) (N=2) 
Allocated to intervention 7-day 
ibuprofen group (N=31) 
♦ Received allocated 
intervention (N=29) 
♦ Did not receive allocated 




Lost at 1 year follow-up 
(regret) (N=2) 
Lost at 6 weeks follow-up 
(regret) (N=2) 
Lost at 1 year follow-up 
(death) (N=1)                    
Discontinued intervention 
(side effects) (N=1) 
Follow-Up 
Analyzed:    
♦ Pain in 14 days (N=29), 1 excluded 
from analysis (lost pain diary)                          
♦ Radiological migration (N=30)                          
♦ Range of wrist motion (N=29)      
♦ DASH score (N=28), 1 patient 
excluded due  to more than 3 
questions not answered                                         
♦ DXA scanning (N=29)                 
Not performed (N=1)                          
♦ Bone biomarkers (N=30)                 
♦ Bone biopsy (N=28)                    
Excluded from analysis (bad quality 
of biopsy material) (N=2)    
                             
Analyzed: 
♦ Pain in 14 days (N=28), 2 
excluded from analysis (lost pain 
diary)                      
♦ Radiological migration (N=30)   
♦ Range of wrist motion (N=28)                                    
♦ DASH score (N=27), 1 
excluded due to contralateral 
wrist fracture                                                 
♦ DXA scanning (N=28)             
♦ Bone biomarkers (N=29)          
♦ Bone biopsy (N=28)    
Excluded from analysis (bad 
quality of biopsy material) (N=1) 
 
Analyzed:    
♦ Pain in 14 days (N=29)                   
♦ Radiological migration (N=28), 1 
excluded from analysis due to 
improper picture quality                
♦ Range of wrist motion (N=27)                            
♦ DASH score (N=27)                                          
♦ DXA scanning (N=28)                  
♦ Bone biomarkers (N=28)               
♦ Bone biopsy (N=27)         
Excluded from analysis (bad quality 























                                                                                                                                    
Figure 5.14. Surgical division - consort flow diagram (reproduced from references 
No. 1 and No. 2). 




5.2. RADIOLOGICAL OUTCOMES 
The primary outcome was to assess the mean difference in radius tilt between the first 
measurement and the 5/6-week follow-up. The results showed that this difference 
followed the same trend in all groups, moving from a volar tilt towards a dorsal tilt. 
The secondary outcome in this part of the study was to assess the mean difference in 
radius length between the first measurement and the 5/6-week follow-up. The results 
showed that this difference followed the same trend in all groups; the radius was 
shortened after 5 - 6 weeks. Another secondary outcome was to assess the mean 
difference in radius inclination between the post-treatment measurement and the 5/6-
week follow-up assessment, wherein a decreased radius inclination was found in all 
groups.  
There were no clinically important or significant changes in radial tilt, length, or 
inclination in the conservative division, 0.09  P  0.5 (Figure 5.21). Severe 
secondary dislocations were reported in one participant in the placebo group, two 
participants in the 3-days ibuprofen group, and four participants in the 7-days 
ibuprofen group at the first one-week follow-up. Three patients were enrolled with an 
unstable Colles’ fracture (one in each treatment group) despite not meeting the 
inclusion criteria. All these patients were subsequently excluded and treated 
surgically. 
There were neither clinically nor statistically significant differences in the surgical 
division (0.12  P  0.87) in the movement of radiological fragments (Figure 5.22). 
Length, tilt, and inclination were measured twice in each X-ray picture by the same 
evaluator. The mean difference in length was −0.184 mm (95% CI: −0.29 to −0.79 
mm), indicating a trend for the radius to be longer at evaluation two. The mean 
difference in tilt was 0.21 (95% CI: −0.011 to 0.43). The mean difference in 





















Changes in tilt (± 1 SD)















Changes in length (± 1 SD)











Changes in inclination (± 1 SD)





















                                                                                                                                                                                                                       
Figure 5.21. Radiological fragment migration of the radius in the conservative 
division. 
P = 0.5 
P = 0.09 
P = 0.22 
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Figure 5.22. Radiological fragment migration of the radius in the surgical division. 
P = 0.74 
P = 0.87 
P = 0.12 
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5.3. FUNCTIONAL OUTCOMES 
The mean DASH score measurement followed the same trend in all groups in both 
divisions, with a high score at three months (conservative division 16.7 ± 14.5, 
surgical division 21.7 ± 14.7) and a lower score at one year (conservative division 
11.3 ± 13, surgical division 13.5 ± 12.8). We did not detect any significant differences 
in ibuprofen and placebo groups at any of the follow-up moments. In the conservative 
division, 0.7  P  0.9, in the surgical division, 0.2  P  0.7 (Figure 5.31). 
Participants in all three intervention groups of the conservative division recorded a 
similar improvement in wrist joint motion during subsequent control sessions. This 
improvement was as great as 88 - 95% of the physiologic ROM at the end of follow-
up (Figure 5.32). No significant differences between the study groups were observed 
during all follow-up time 0.1  P  0.9. 
In the surgical division, patients in all groups showed improved wrist joint motion 
corresponding to 87% - 95% of the normal contra-lateral wrist movement at the final 
visit (Figure 5.33). The differences between the therapy groups were not significant 
during the entire follow-up process, 0.1  P  0.6. 
There was no difference in the distribution of injured hand domination between the 
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Figure 5.32. ROM changes in the injured wrist, conservative division. 
0.15 ≤  P ≤ 0.9 
 
0.27 ≤  P ≤ 0.83 
 
0.1 ≤  P ≤ 0.77 
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Figure 5.33. ROM changes in the injured wrist, surgical division. 
0.1 ≤  P ≤ 0.52 
0.17 ≤ P ≤  0.44 
 
0.18 ≤ P ≤ 0.6 
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BMD of fractured bone compared to healthy 
bone (± 1 SD) - surgical division
5.4. DENSITOMETRICAL OUTCOMES 
In both divisions, the injured bone showed a mean BMD that was 3 - 7 % higher in 
the ultra-distal region of interest than in the healthy contra-lateral radius. This trend 
was observed in all treatment groups, with no significant difference between them. 
(Figure 5.4).  
 







    








                                                                                                                                      
Figure 5.4. Densitometrical outcomes in treatment groups. 
P = 0.69 
P = 0.72 














Serum CrossLaps (± 1 SD) - conservative 
division













Serum Osteocalcin (± 1 SD) - conservative 
division
placebo group 3-days ibuprofen group 7-days ibuprofen group
5.5. BIOCHEMICAL OUTCOMES 
This study did not demonstrate any difference in CrossLaps and Osteocalcin levels at 
any moment of the follow-up time. In the conservative division, the significance was 
0.06 ≤ P ≤ 0.7 for CrossLaps, and 0.15 ≤ P ≤ 0.84 for Osteocalcin (Figure 5.51). In 
the surgical division, it was 0.37 ≤ P ≤ 0.95 for CrossLaps, and 0.43 ≤ P ≤ 0.99 for 


















                                                                                                                                    
Figure 5.51. Biochemical outcomes in the conservative division. 
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Serum CrossLaps (± 1 SD) - surgical division
Placebo group 3-days ibuprofen group 7-days ibuprofen group




5.6. HISTOMORPHOMETRIC OUTCOMES 
Neither volume nor surface estimations were significantly different in intervention 
groups, 0.38 ≤ P ≤ 0.99 (Table 5.6). The median intra-observer CV was equal to 4.7%, 
ranging from 0 - 36.9%. The evaluator tended to identify less tissue as a woven bone 
and less bone surface as a "quiet" type (without signs of bone resorption or 
formation/remodeling) (2). 
Table 5.6. Histomorphometric estimations (mean ± 1 SD) in treatment groups of the 
surgical division. 
 
5.7. ANALGESIC OUTCOMES 
The mean daily pain score evaluation showed a constant decrease in pain in all 
treatment groups across all 14 days in the conservative division. Pain in the first three 
days was 1.3 VAS points (on average) less intense among the ibuprofen patients (P = 
0.02) in comparison to the placebo therapy, where the peak difference of 1.75 VAS 
points was noticed during the second day (Figure 5.71).   
The placebo group demonstrated a slighter decrease in pain until day 8. Pain 
experienced in this group was 0.8 VAS points higher during the 4 - 7 days follow-up 
(compared to the ibuprofen groups). During the third period of 8 - 14 days, all the 
groups scored equally between 2 and 3 VAS points. No significant differences were 
observed during these follow-up periods. (Table 5.72). 
  placebo group 3-days ibuprofen group 7-days ibuprofen group  P 
BV/TV% 26.6 ± 8 28 ± 8.5 26.3 ± 5.7 0.68 
WBV/TV% 4.4 ± 2.5 6 ± 5.3 4.2 ± 2.3 0.77 
LBW/TV% 18.5 ± 8.5 18.5 ± 7.7 18.5 ± 7.5 0.99 
FV/TV% 50 ± 17.1 46.4 ± 12.2 49 ± 12.3 0.61 
OV/TV% 3.6 ± 1.5 3.4 ± 1.8 3.6 ± 1.6 0.84 
OS/BS% 47.3 ± 14 41.4 ± 16.5 43.7 ± 17.3 0.38 
ObS/BS% 14.8 ± 8.7 11.7 ± 9.9 14.6 ± 11 0.43 
OcS/BS% 9.8 ± 5.6 10.3 ± 5.6 10.4 ± 5.8 0.91 
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division











Figure 5.71. Pain dynamics in the conservative division. 
 
Table 5.72. Mean pain score in treatment groups of the conservative division. 
 
Tramadol consumption was seen in 12.5% of the population in the 3-days ibuprofen 
group, 26% of the population in the 7-days ibuprofen group, and 33.3% of the group 
population in the placebo group of the conservative division (Figure 5.73). The 




Day placebo group 3-days ibuprofen group 7-days ibuprofen group P 
1-3 4.93 (SD 2.25) 3.66 (SD 1.63) 3.61 (SD 1.15) 0.02 
4-7 3.35 (SD 1.86) 2.8 (SD 1.33) 2.38 (SD 0.89) 0.23 
8-14 2.38 (SD 1.37) 2.2 (SD 1.07) 2.5 (SD 1.49) 0.58 
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Figure 5.73. Tramadol use on request in the conservative division. 
                                                                                                                             
Measurement of the mean daily pain score in the surgical division showed a constant 
decrease in pain in the 7-days ibuprofen group across all 14 days. The mean pain score 
was not significantly different between the treatment groups in the predefined follow-
up intervals mentioned above (Table 5.74).  
The placebo group demonstrated increasing pain between day one and day two (3.9 
to 4.4 points), after which the pain score decreased continually. The 3-days ibuprofen 
group experienced increasing pain from the third to fourth day. The peak pain score 
was 4.4 and decreased from day 4 to day 14. This decrease was seen to a lesser extent 
than in the other treatment groups (Figure 5.75). 
Table 5.74. Mean pain score in the different treatment groups of the surgical division. 
Day placebo group 3-days ibuprofen group 7-days ibuprofen group P 
1-3 4.18 (SD 1.9) 4.25 (SD 1.71) 4.3 (SD 1.92) 0.4 
4-7 2.98 (SD 1.88) 3.88 (SD 2.04) 2.98 (SD 1.47) 0.13 
8-14 2.18 (SD 1.35) 2.54 (SD 1.75) 2.17 (SD 1.0) 0.98 



















Tramadol daily consumption (mean ± 1 SD) in 
the surgical division 
placebo group 3-days ibuprofen group 7-days ibuprofen group
 
Figure 5.75. Pain dynamics in the surgical division. 
In surgical division, tramadol consumption was seen in 79% of the population in the 
placebo group, 71% of the population in the 3-days ibuprofen group, and 57% of the 
population in the 7-days ibuprofen group. The peak difference was seen on the second 
day (Figure 5.75). The median of tramadol consumption during the first three days 
was 2 (range 0 - 7) pills in the placebo group and 1 (range 0 - 9) pill in the NSAID 
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Proportion of patients with adverse events -
conservative division
P = 0.03P = 0.19
5.8. COMPLICATIONS AND ADVERSE EVENTS 
Conservatively treated patients complained mostly of gastrointestinal disturbances 
and finger dysesthesia (Table 5.81). For this part of the study, the total percentage of 
adverse events counted was 46.1%, with significant differences between 3-days 
ibuprofen and placebo groups, Z = 1.91, P = 0.03 (Figure 5.82). 
 
 Adverse events placebo group 3-days group 7-days group 
Overall 
11 of 31 
(35.5%) 
17 of 30 
(56.6%) 
13 of 30 
(43.3%) 
Gastrointestinal disorders 3 3 7 
Numbness 4 6 3 
Swelling 3 4 1 
Serious secondary displacement 1 4 2 











                                                                                                                                   
Figure 5.82. Proportion of patients with adverse events – conservative division. 





































The surgical division's overall adverse events rate was 43.9%. The gastrointestinal 
disorder was the most common complication; however, no therapy-related severe 
complications were observed in any treatment group. Other complications relating to 
fracture or surgery, nerve numbness, pinhole infections, loosening of osteosynthesis 
material, and secondary fracture-dislocation, were observed in 19 patients, 21.3% of 
the division population (Table 5.83). 
There were significant differences in the number of adverse events between ibuprofen 
and placebo-treated patients (Z = 1.709, P = 0.043, Figure 5.84).  
 
 Adverse events placebo group 3-days group 7-days group 
Overall 
10 of 30 
(33.3%) 
12 of 30 
(40%) 
16 of 29 
(55.1%) 
Gastrointestinal disorders 4 7 8 
Numbness 6 2 5 
Pinholes Infection 0 1 2 
Loosening of osteosynthesis 
material 
0 2 0 
Serious secondary displacement 0 0 1 














CHAPTER 6. DISCUSSION 
6.1. MAIN FINDINGS 
• All treatment groups with a Colles’ fracture demonstrated the same bone 
fragment migration pattern regardless of the ibuprofen therapy for 
conservatively and surgically treated patients. 
 
• All treatment groups in both divisions demonstrated the same improvement 
in DASH score and wrist joint motion amplitude, regardless of whether they 
were treated with ibuprofen (and for how long) or not. 
 
• All treatment groups in both divisions presented the same results expressed 
in bone mineral density in the fracture zone three months after injury. 
• The same trend of serum CrossLaps and Osteocalcin concentration changes 
were demonstrated in all treatment groups, regardless of the ibuprofen 
treatment. 
 
• There were no differences in histomorphometric volume and surface 
estimations in callus biopsies in all surgical division groups, regardless of 
the ibuprofen treatment. 
 
• This study demonstrated statistically significant pain relief in the ibuprofen 
groups of the conservative division and a tramadol-sparing effect in the 
ibuprofen groups of the surgical division. 
• The overall adverse effects (predominately gastrointestinal disturbances) 
were more frequent among ibuprofen than placebo-treated individuals in 
both divisions. In the conservative division, most secondary displacements 
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6.2. INTERPRETATION OF THE RADIOLOGICAL OUTCOMES AND 
COMPARISON WITH THE LITERATURE 
This study has shown that short-term ibuprofen therapy did not affect the 
consolidation of distal radius fracture in terms of radiological outcomes. Embase and 
PubMed's search engines helped us identify two studies describing analgesic, 
functional, and radiological outcomes after Colles’ fracture related to NSAID therapy 
(49,72). 
Davis and Ackroyd (49) treated Colles’ fracture patients conservatively for two weeks 
in a double-blind, prospective randomized study using flurbiprofen. The authors 
examined the anatomy of the post-traumatic radius in one year's radiographs. They 
reported 64% of injuries uniting in an excellent position according to Lidström 
classification, matching the excellent anatomy near in 61% of our study population.  
Additionally, Davis and Ackroyd reported a paracetamol-sparing and noticeable 
analgesic effect of flurbiprofen during the first three days. However, the different 
flurbiprofen dosing in the treatment group and the differing ages of 8.4 years on 
average between the individuals in study groups make the direct analogy with our 
results somewhat challenging. Furthermore, the authors reported the analgetic results 
in categorical units. 
Adoplphson et al. carried out an RCT  consisting of two groups with 21 women after 
menopause suffering from Colles’ fracture and treated conservatively (72). The 
intervention group was assigned to piroxicam for eight weeks, while the other group 
was given a placebo and paracetamol as an escape medication. Shortening of the 
radius by 2 - 3 mm and progressing dorsal tilt by 12 - 14° in both study groups was 
not significantly different.  This study also contained a minor sample of severe, multi-
fragmented fractures allocated to conservative treatment, and 14% of the participants 
were later treated surgically, applying an external fixation. These may be seen as 
confounding factors in this study’s results. 
 
A bridging external fixation with supplemental K-wires for fixation of Colles’ fracture 
being described as a valid tool in fracture stabilization (73), osteosynthesis's rigidity 
remains not entirely static, and bone fragments may migrate as much as six weeks 
after the operation (74). Using the keywords “Colles’ fracture” and “NSAIDs” in the 
PubMed and Embase search systems produced only two studies (49,72) with the 
radiological migration of Colles’ fractures following NSAID treatment as the main 
topic. However, both these studies involved conservative treatment, and their 
outcomes are, therefore, not closely comparable with the fragment migration in our 
surgical division. 
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Other studies reporting radiological outcomes of bridging external fixation of Colles' 
fracture were compared with this study, although none used NSAIDs for pain 
treatment. 
Wei et al. compared different osteosynthesis types six weeks after surgery in their 
randomized prospective study (65). They observed inclination, tilt, and length in the 
individuals treated with external fixation, similar to the results observed in our trial.  
Wright et al., in the prospective/retrospective cohort study on external fixation and 
palmar plate osteosynthesis, compared radiological outcomes at the 47-month follow-
up and observed volar tilt and radial inclination outcomes comparable to our results 
(75). 
Howard et al. used external fixator-type bridging (without additional K-wires) and 
found an approximate 1 mm radial shortening and a 1 volar tilt reduction on average 
in a population of 50 patients at three months (76). Jenkins and Jones used external 
fixator-type non-bridging for 58 patients and found the loss of volar tilt to be 0.1, the 
inclination to be 0.7, and the length to be 0.3 mm. The authors noted that this was 
below the measurement accuracy level (77). 
Intra-observer variation in this study was expressed as the mean difference between 
the two measurements. The difference was smaller than 1° or 1 mm, which Watson et 
al. (66) considered as the limits of reliable measurements and was below the clinically-
relevant margin described by Gartland et al. (54). The minor difference between the 
repeated measurements may be explained by having both positive and negative 
differences, which can neutralize each other. The intra-observer coefficient of 
variation may be used as an alternative estimate (78); however, such an assessment 
cannot demonstrate the systematic measurer’s error.  
Our work demonstrated an identic trend of radiological migration in all intervention 
groups, and the grade of secondary dislocation was not significantly different. The 
differences in the groups' primary and secondary outcomes were smaller than the 
standard deviation inside the groups; therefore, the radiological outcomes are entirely 
comparable. Patients in the surgical division achieved sufficient distal radius 
inclination, tilt, and length, which, compared to the bone's normal anatomy, crucial 
for later wrist movement as depicted by Dario et al. (34). The intra-observer 
agreement needs to be considered when more significant differences between 
treatment groups are shown. 
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6.3. INTERPRETATION OF THE FUNCTIONAL OUTCOMES AND 
COMPARISON WITH THE LITERATURE  
This study did not identify a significant effect of a brief ibuprofen therapy wrist 
movement after Colles' fracture. No differences within the DASH score between the 
intervention groups were revealed during the follow-up period in either the 
conservative or surgical divisions. 
The search engines Embase and PubMed helped us identify two studies describing 
functional outcomes after Colles’ fracture related to NSAID therapy (49,72). 
Davis and Ackroyd (49) treated Colles’ fracture patients conservatively using 
flurbiprofen for two weeks in a double-blind, prospective randomized research. 
According to the researchers, both intervention groups' participants regained 95 - 99% 
of normal wrist flexion after one year, which matched our study results. Different 
flurbiprofen dosing along the differing ages of 8.4 years on average in the treatment 
groups make direct comparability rather tricky. 
An RCT conducted by Adolphson et al. (72) investigated two groups of 21 
postmenopausal females, each with conservatively treated Colles’ fractures. The 
researchers prescribed piroxicam to one group for eight weeks, while the other group 
received a placebo, and paracetamol was used as a rescue drug. They observed similar 
functional outcomes after three months of follow-up. Patients achieved 70% of normal 
wrist deviation, 76% of normal wrist flexion, and 95% of regular forearm rotation. A 
minor number of displaced multi-fragmented fractures were allocated to cast 
treatment, and 14% of the participants were later treated surgically, applying an 
external fixation. These factors may also be confounding this study’s results.  
In this study, ibuprofen was prescribed in the acute phase of pain after surgical 
treatment. Therefore, a further study with a prolonged NSAID treatment of several 
weeks to months might provide more persuasive arguments in revealing the actual 
influence on clinical outcomes and adverse events. Such prolonged therapy tends to 
increase the risk of renal, gastrointestinal, and cardiovascular disorders (79); in our 
opinion, the postoperative pain after osteosynthesis of Colles’ fractures does not 
require extended treatment. 
A search using Medline and Embase, performed with the keywords Colles’ fracture 
AND ibuprofen AND DASH score, did not identify any studies that described 
ibuprofen's influence on the DASH score after Colles' fracture. A retrospective study 
(80), which investigated predicting factors to DASH score after Colles’ fracture, 
reported a median DASH of 6 at six months for conservatively treated patients, a result 
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similar to our one-year outcome of 6.3. Grafstein et al., in their prospective study of 
conservatively treated Colles’ fractures, reported a mean eight-week DASH equal to 
34.6, and a six-month DASH equal to 20.3 (81). The two-year follow-up control of 
displaced Colles’ fractures by Aktekin (82) found the same result. Enrolment of 
participants with unstable fractures can explain the higher score. 
Wright et al. (75) performed a retrospective study to compare the functional outcomes 
following palmar plate osteosynthesis and external fixation of Colles’ fractures, 
reporting a comparable DASH outcome in the external fixation group at the 47-month 
follow-up. In their cohort study of volar plated fractures, Kamath et al. (83) found 
mean DASH values and wrist motion results at the 18-month follow-up similar to the 
outcomes presented here. The patients in this study's surgical division also presented 
DASH scores similar to participants in the palmar plating group in a survey by Richard 
et al. (84). 
Werber and al. (73) performed a five-pin external fixation, comparable to the 
osteosynthesis method in this study. They also compared the range of motion with the 
contralateral wrist and found that, at the six-month control, pronation/supination was 
85% ± 12, flexion/extension was 78% ± 23, and radial/ulnar deviation was 62% ± 20. 
These results fill the gap between our three-month and one-year observations. 
External fixation-type bridging with additional K-wires is an efficient operation (51), 
and our study supports this conclusion. Wrist mobility and function improved in all 
surgically treated patients during the first year after injury; they achieved 87% - 95% 
of normal wrist range of motion on average. All treatment groups demonstrated 
similar improving patterns without any statistically significant differences. 
 
6.4. INTERPRETATION OF THE DENSITOMETRICAL OUTCOMES 
AND COMPARISON WITH THE LITERATURE 
We did not observe any differences in BMD values in the distal radius between both 
divisions' treatment groups. The average BMD was 3 - 7 % higher in the ultra-distal 
region of the affected radius than in the healthy contra-lateral bone. 
As far as we are aware, there is only one previous study investigating NSAID’s 
influence on the mineral density of an injured and non-injured distal radius. The 
double-blinded RCT conducted by Adolphson et al. (72) revealed no difference in 
bone mineral content changes between groups on piroxicam and placebo treatments 
at the eight-week control. However, because the researchers examined the radius 
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proximal from the fracture, it is not easy to directly compare their outcomes with our 
results. This study's validity might also be affected by the minor sample size, 
enrollment of displaced, multi-fragmented distal radius fractures allocated to 
conservative therapy (which were then treated surgically and excluded from BMD 
evaluation). 
An investigation of alendronate’s influences on BMD in the distal radius was 
conducted by Van der Poest et al. (69). In the present study, baseline DXA scanning 
carried out three months after the injury found the total BMD of the distal radius equal 
to 0.40 g/cm2 ± 0.05. As a majority of Colles' fractures appear at distal 38 mm of the 
radius (85), we believe assessing the ultra-distal region of interest to evaluate bone 
consolidation is more reasonable.  
Eastell (86) measured the UD distal radius region in 40 females following Colles' 
fracture and reported a BMD similar to our findings. Moreover, researchers state that 
fracture risk increases significantly with a BMD below 0.4 cm2 in the distal radius. 
Our densitometry demonstrated a total BMD in the healthy contra-lateral bone of 0.33 
± 0.06 g/cm2, which confirms the authors’ observation. 
 
6.5. INTERPRETATION OF THE BIOCHEMICAL OUTCOMES AND 
COMPARISON WITH THE LITERATURE 
All the treatment groups in our study demonstrated similar patterns of changes in 
serum CrossLaps and Osteocalcin concentration, irrespective of ibuprofen treatment. 
Bone biomarkers are often used as an evaluation tool for the investigation of the 
treatment of osteoporosis. Nevertheless, because fracture recovery is related to 
increased bone turnover, some attempts have been made to observe fracture recovery 
using biochemical assays. Three studies describing changes of Osteocalcin and 
CrossLaps following Colles’ fracture were identified in our review of the literature.  
Ingle et al. recorded changes in bone resorption and remodeling markers (87); they 
observed a 15% increase of Osteocalcin. We observed an increase of 7% in the 
conservative division until the third month of control, and CrossLaps also increased 
during the first two weeks of follow-up, returning to original levels at one years’ 
control in both divisions. 
Mallmin et al. (88), in their study, recruited 16 participants suffering from a Colles’ 
fracture and observed a small but continual Osteocalcin’s rise of 1 ng/ml during their 
16 weeks follow-up, similar to our 3-months findings in both divisions. 
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Wolfl et al. looked at 30 patients suffering from fractures in metaphyses, 14 of whom 
sustained a Colles’ fracture (89), and found that CrossLaps continuously increased in 
the regular BMD-bone group, whereas, from the first week, these levels dropped 
significantly in the low BMD-bone group. Because enrolled patients received both 
surgery and conservative treatment, and the follow-up was brief, the results cannot 
match our outcomes closely. 
The findings allow us to conclude that the explicit agreement regarding bone 
biomarkers’ role in monitoring fracture recovery is still not validated (90,91). The 
notably variating biomarkers’ concentrations between individuals imply the presence 
of numerous confounders such as sex (92), age (93), osteoporosis, and metabolic 
diseases (94). Therefore, further investigation is necessary to adequately describe the 
value of resorption and remodeling biomarkers in monitoring bone consolidation. 
 
6.6. INTERPRETATION OF THE HISTOMORPHOMETRIC 
OUTCOMES AND COMPARISON WITH THE LITERATURE 
The research of metabolic diseases and fracture healing makes wide use of animal 
models for histomorphometric bone analysis (29). However, there is little data that 
describes the human cancellous bones' fracture recovery in terms of 
histomorphometric estimations (46). Our study assumed that the fracture undergoes 
the process of endochondral ossification and the building of a new woven bone. We 
presumed that, by impaired fracture, fewer bone fractions and more fibrous tissue 
would be presented, and we hypothesized less bone formation and more resorption 
surfaces to be found. The importance of the histologic part of the study was amplified 
as no difference in volume and surface estimations was depicted despite carrying out 
eight statistical analyses between three intervention groups.  
 
6.7. INTERPRETATION OF THE ANALGESIC OUTCOMES AND 
COMPARISON WITH THE LITERATURE 
This study reveals significantly different analgesic symptoms in the conservatively 
treated ibuprofen and placebo groups. Patients treated with ibuprofen reported the first 
days’ pain experience, which was lower by 1.3 VAS points on average, than in the 
placebo group. Ibuprofen groups also demonstrated a trend for better pain relief as 
long as they were treated with NSAID. This analgesic effect and pain reduction were 
delayed from day 4 in the 3-days ibuprofen group, related to ibuprofen-placebo 
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turnover. There was a tendency for higher tramadol consumption in the placebo group, 
but the difference was not significant in the conservative division. 
In the surgical division, all patients using paracetamol as the primary medication and 
tramadol as a rescue pharmaceutical received sufficient analgesic treatment, 
regardless of ibuprofen therapy. The participants in the 3-days ibuprofen group also 
experienced more intense pain during the third and fourth day, which corresponds 
with the replacement of ibuprofen with the placebo. Furthermore, the pain continued 
to be more intense during the whole 14-day follow-up time in the 3-days ibuprofen 
group.  
The placebo group showed significantly higher tramadol use over the first three days 
than the ibuprofen-treatment groups in the surgical division. This study also 
demonstrated a clinically relevant tramadol-sparing effect. Individuals allocated to 
three days’ ibuprofen or placebo therapy experienced a higher demand for tramadol 
than participants allocated to the 7-days group. The explanation might be that they 
tended to use escape medication to suppress their pain to the level they were likely to 
accept.  
Davis et al. (49) studied flurbiprofen's use for treating Colles' fracture in a 14-day long 
prospective study. The researchers observed a significant reduction in pain and 
paracetamol use during the first three days in the intervention group. The outcome 
was reported, however, in categorical units. The interpretation of these results is also 
difficult due to the significantly differing age (8.4 years on average) and different 
study medication doses. 
Adolphson et al. (72) conducted a double-blind RCT allocating postmenopausal 
women suffering from Colles' fractures to two intervention groups, each with 21 
participants. One group was prescribed piroxicam for eight weeks, with the other 
group receiving a placebo, and paracetamol was provided as an escape analgesic. 
Using a VAS scale, the pain was assessed as 3.1 in the placebo group and 2.1 in the 
piroxicam group on day ten. The demand for escape analgesics was significantly 
higher among placebo patients. The research was conducted with a small number of 
participants suffering from severe multi-fragmented fractures, allocated for plaster 
cast therapy, and subsequent operation with an external fixation on 14% of them. The 
pain experience and functional outcomes in this study may have been somewhat 
distorted by the severity of the injury and treatment method.  
The influence of transcutaneous electric nerve stimulation (TENS) on analgesic 
symptoms after a Colles’ fracture was assessed by Lee et al. (95). They reported that 
the TENS therapy diminished the mean pain score symptoms from the average of 5.5 
VAS points on the first day to 3.5 VAS points on the fourth day. All patients were 
CHAPTER 6. DICUSSION 
75 
 
treated surgically by using a palmar plate and received NSAIDs. The outcome is 
comparable with the results of our study. Participants in the surgical division reported 
minor pain experiences over the first few days, probably due to the minimally invasive 
surgery in our study. 
The data presented in this work shows reduced tramadol consumption during and after 
short-term ibuprofen treatment (compared to placebo) in treating unstable Colles’ 
fractures. The pain level was not significantly different between these groups in the 
surgical division.  
These results suggest that ibuprofen treatment in the acute phase may be favorable as 
an analgesic, as Kyriacou reported (6). Furthermore, ibuprofen may have an opioid-
sparing effect, as our study also indicates. The mean age of participants in this study 
was 62 - 65 years, and up to 18% of all fractures in the > 65s are distal radius fractures 
(85). Opioid-induced side effects and complications in the acute phase (i.e., urinary 
retention, constipation, delirium, and respiratory depression) increase with age (96); 
therefore, the opioid-sparing treatment with ibuprofen may be beneficial for older 
patients in orthopedics. 
 
6.8. INTERPRETATION OF COMPLICATIONS AND ADVERSE 
EVENTS AND COMPARISON WITH THE LITERATURE 
All treatment groups presented some degree of gastrointestinal disorders in both 
divisions, including those patients treated with a placebo only (13.3% incidence rate 
in the conservative division, 14.2% in the surgical division). It indicates that some 
patients may have experienced gastrointestinal disorders due to reasons other than 
ibuprofen during the first days after trauma and operation. This fact is worth 
considering when making decisions about the side-effects of ibuprofen.  
The adverse event rate in the conservative division was 10% in the 3-days and 23.3% 
in the 7-days group. For surgically treated patients, the number was 23.3% and 27.6% 
in respective groups.  
Our study's adverse event rates were more numerous than the 15% revealed in 
published works reporting oral NSAIDs therapy (97). The results become comparable 
if gastrointestinal disorders in the placebo group are considered. No prophylactic 
proton pump inhibitors were used (unnecessary for patients receiving placebo). On 
the other hand, acid-neutralizing medicine might have reduced the number of 
gastrointestinal symptoms in the study population. 
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The secondary fracture displacements in the conservative division we observed might 
advocate the dose-independent ibuprofen’s affection of radiological migration, but we 
did not observe the pattern in surgically treated patients. The explanation might be 
that due to ibuprofen’s oedema-reducing effect, the injured wrist regains the normal 
scope earlier, and thus the immobilizing cast becomes relatively too loose.  
 
6.9. METHODOLOGICAL CONSIDERATIONS AND STUDY 
LIMITATIONS 
The first limitation of this trial is the shortage of a pilot study. Such a pilot project 
would allow the precise and proper power calculation in all outcomes and define the 
subsequent study as definitive. Due to the shortage of time, specific local regulations, 
and pilot studies requirements, a literature-based power calculation was made. 
Therefore, it is reasonable to define this study as exploratory one. 
A selection bias might also be considered as the enrolment rate was limited to 33.8%. 
This rate can likely be explained by the fact that thorough participants’ information, 
signing the consent, assessing and recording the baseline values resulted in a 
significant logistical challenge. The personnel involved had insufficient time for the 
process. Furthermore, there were differences in age (non-included patients were 2,5 ± 
0.99 years older) and sex (7% more males among included patients). These significant 
differences might be explained by the large sample sizes of 191 enrolled and 373 non-
enrolled patients.  
The difficulty of treatment standardization was a third potential limitation of this 
study; as patients did not sustain their fractures simultaneously, some received 
medication at the beginning of the first day while the remaining patients were injured 
(and suffered from pain) in the afternoon of day one. This injury-time variation may 
cause some inconsistency in the timing of their first and last medication intake after 
the injury. In turn, uncertainty about the first day's pain symptoms and diary records 
might appear. While efforts were made to enroll all participants during the first 
hospital visit, it was impossible to guarantee that all participants were taking 
analgesics simultaneously after the accident. Furthermore, some persons, believing 
that they only suffered from a sprain or contusion, waited one or more days, thus only 
presenting at the hospital after several days. Others were not invited to be part of the 
study because the personnel had no time to inform patients, and so the investigator 
was left to inform the patients 1 - 2 days later. As a result of these logistical difficulties, 
ensuring that ibuprofen was simultaneously administered during the inflammation 
phase of the fracture was unachievable.  
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To some extent, this variability is atoned by the randomization and sufficient size of 
the treatment groups.  
Despite our instructions to the contrary, three participants suffering from Older type 
3 - 4 fractures were admitted to the conservative division due to unexpected successful 
anatomic reduction. These patients were excluded from the study at the one-week 
control when secondary dislocation was detected (due to the high instability of the 
fracture). 
 
The surgical treatment chosen in this study was external fixation. In the middle of our 
study's enrollment phase, a volar plating became the osteosynthesis method of choice, 
as depicted in the new Danish National Guidelines for treatment of distal radius 
fracture 2014 (98). Volar plating allows early mobilization (which could be better 
suited for early evaluation of ibuprofens’ influence on functional outcomes) and 
minimizes the risk of secondary fragment dislocation (99). Nonetheless, this trend of 
using volar plating for unstable Colles’ fracture is not always supported by evidence-
based superiority (100) and still remains one among several methods of choice (52). 
External fixation offers bone healing research opportunities such as callus biopsy and 
DXA-scanning of both wrists, free from metal artifacts. For those reasons, we did not 
change the study protocol.  
 
It was also not realistic to perform the surgery simultaneously after trauma due to a 
busy acute operations schedule and a lack of hospital capacity. This irregularity 
resulted in varying moments when the pain was reduced by peripheral nerve block 
over the first three days. It might also explain some inconsistencies in patients' pain-
diary records. 
The use of escape medication was self-reported in the patients’ pain diary. To 
compensate for this limitation, occupational therapists assigned to this study counted 
pills at one-week and two-week controls. As most of the analgesic treatment took 
place in participants’ homes, we had no opportunity to use automated dispensation 
recorders. 
A lack of exact standardization in placing the injured arm in the X-ray beam at lateral 
projections provided another potential limitation. It is not unlikely that the arm's 
position may differ by a few grades of rotation, affecting the following tilt evaluation. 
The measuring of the radius length also provided some uncertainty. The operations 
were performed with an image intensifier as a quality control implement, and the 
radiographs were stored for documentation and assessment. The length was reported 
by the EazyViz software in pixels in those radiographs, while standard X-ray EazyViz 
software from the outpatient clinic reported in millimeters in its length evaluation. For 
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this reason, a 1.4 mm osteosynthesis K-wire was chosen as the calibration tool to 
assess the thickness of the wire in pixels and establish an individual pixel value. Thus, 
the perioperative length of the radius was determined. Despite this, the blurring of the 
lines of the K-wire on the digitally zoomed radiograph caused some uncertainty. 
These limitations and the intra-observer agreement need to be considered, mostly if 
any statistically significant differences are observed.  
A current local standard regime for follow-up after Colles’ fracture allowed 
radiological controls after one, two, and five/six weeks. The possibility of a late 
collapse of the fracture after removal of K-wires and external fixation persists, 
although this complication is unlikely (101). A further radiological evaluation would 
also mean higher patients’ exposure to X-ray radiation. We decided, therefore, not to 
perform further radiological investigations.  
We did not include finger movement and grip strength in the functional outcomes for 
specific reasons. Grip strength varies between individuals and, even in the same 
individual, may be influenced by the patient’s handedness (102,103). Finger 
movement may be influenced by the positioning of fixator pins in the second 
metacarpal bone and was not selected as an outcome in this study's planning. 
A small number of patients did not attend their final follow-up sessions to evaluate 
the wrist range of motion and DASH-score. Another limitation was the measurement 
of range of motion, which may be subject to inter and intra-observer variation. The 
DASH-score is a composite self-reported outcome with some information lost by 
calculating the score's final value (104). For these reasons, functional outcomes are 
classified only as exploratory in this study. 
 
As the current state of the art does not recommend treatment with NSAIDs for fracture 
patients (12,13), a non-inferiority design for the majority of the outcomes was chosen. 
The main research question was whether ibuprofen is harmful to patients with Colles’ 
fractures. Therefore, the study was designed as a non-inferiority trial with an 
appropriate one-sided significance test (68) of radiological, functional, biochemical, 
and histomorphometric outcomes. A superiority test can be added without losing the 
power and adjusting p-value for multiple comparison tests (68) if the results 
demonstrate a trend towards the unexpected (being better) effect. We did not observe 
such a trend.  
A notable restriction of the non-inferiority trial is whether the sample size used 
included a sufficient number of participants. Nonetheless, in this study, the between-
group differences were minor, less than 10% - 30% of the within-group standard 
deviations. Therefore, this study's sample size can be considered sufficient to ensure 
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sufficient power with a 0.05 level of significance as favored in non-inferiority studies 
(68). 
There are further influencing factors such as sex, age, suffering from osteoporosis, 
alendronate therapy, body mass index (105), smoking, endocrine diseases, and even 
ethnicity (106,107) that may affect bone metabolism, response mechanisms to the 
injury, and recovery. Hence, ibuprofen can, in theory, affect bone consolidation to a 
different extent. However, the purpose of this study was not to stratify according to 
cofounders such as BMI, ethnicity, or sex. Colles’ fracture incidence is highest in 
women aged over 50 and suffering from osteoporosis (108), and control of these 
cofounders is rather challenging.  
 
The central limit theorem was a crucial issue we relied on while designing our 
research. Following the theorem, the body mass index along with other cofounders 
would be similarly distributed in study groups consisting of 30 or more participants 
(91,109). Participants in our study were all Caucasian individuals from the local 
Danish population. None of the patients enrolled suffered from severe obesity. Further 
attempts were made to enhance internal validity. The study was triple- blinded with a 
"blind" surgeon responsible for all interventions and assessing the outcomes. Only 
two occupational therapists measured the range of motion, and a blinded statistician 
worked with the data analysis (1,2,91). 
 
In our research, we worked under the usual conditions, experienced everyday clinical 
situations (91), targeted at the wide population of Colles’ fracture patients. The 
external validity is hereby ensured (110), making us, to some degree, confident in 
generalizing (111). It allows us to declare that ibuprofen therapy of one week’s 
duration is unlikely to hamper the fracture consolidation in the distal radius. Still, there 
are some reservations, and this generalization cannot be automatically adapted in 






CHAPTER 7. CONCLUSIONS 
This study demonstrated that ibuprofen does not hamper fracture healing in the distal 
radius.  
Participants in all study groups presented the same trend of fragment migration during 
the first 5 - 6 weeks as well as bone biomarkers change during one year. 
All patients, regardless of the ibuprofen treatment strategy, regained a similar wrist 
function level by their 1-year follow-up, which was close to 87 - 95% of the uninjured 
contralateral wrist’s range of motion. 
All patients experienced the same pattern of reduction in DASH score points. 
Regardless of ibuprofen treatment and dose, bone mineral density was, on average, 
7% higher in the injured distal radius three months after injury.  
There were no differences between study groups in histomorphometric volume and 
surface outcomes of the newly formed bone. 
Between-groups variation of all these outcomes, as mentioned above, was as high as 
10-30% of the variation within groups. 
This study showed the significant analgesic effect of ibuprofen during the fracture's 
acute phase for patients treated conservatively. Ibuprofen influenced a reduced 
tramadol consumption during the perioperative period of the Colles’ fracture. 
The complication rate in the intervention groups was above the rate observed in the 
placebo groups. 
In conclusion, ibuprofen therapy in the acute phase, compared to placebo, was not 
inferior regarding the radiological, functional, densitometrical, biochemical, and 
histomorphometric outcomes in both divisions and all treatment groups. Ibuprofen 
treatment demonstrated better pain relief for conservatively treated patients and a 
tramadol-sparing effect for surgically treated patients.  
Our study’s findings support the use of ibuprofen as a bone-neutral analgesic. These 
results may have relevance for other fields of orthopedics and traumatology treating 
primary cancellous bone fractures. The risks of side-effects from ibuprofen do, 




CHAPTER 8. FUTURE RESEARCH 
This study's primary purpose, which aimed to investigate whether ibuprofen slows 
healing of Colles’ fracture, is hereby achieved. The results advocate the prescription 
of NSAID as a potentially harmless pharmaceutical in the acute bone healing phase.  
 
The outcomes variation between individuals is high, with some participants presenting 
perfect results and some poor. 
 
There are other data recorded in our study database: smoking habits, alcohol 
consumption, handedness, osteoporosis treatment, occupation, and pain threshold, 
which might be considered confounding factors, and the database, therefore, offers 
the opportunity to perform a multiple regression analysis. 
 
The expectation is that this analysis will contribute to increased knowledge of the 
effects of ibuprofen, making pain management, rehabilitation, and the entire course 
of treatment more comfortable and safer. Hence, patients recover faster and can return 
to their usual activities more quickly. The multiple regression model has the potential 
to predict poorer outcomes allowing patients to receive the optimal treatment and plan 
a follow-up regime to avoid the risk of further wrist malfunction.  
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